Risks of Endometrial Cancer Associated With Different Hormone Replacement Therapies in the E3N Cohort, 1992-2008

Progestogens Used in Postmenopausal Hormone Therapy: Differences in Their Pharmacological Properties, Intracellular Actions, and Clinical Effects

(2013) Frank Z. Stanczyk et al.   ENDOCRINE REVIEWS

Menopausal hormone therapy and risk of endometrial cancer

(2013) Louise A. Brinton et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

EMAS clinical guide: Low-dose vaginal estrogens for postmenopausal vaginal atrophy

(2012) Margaret Rees et al.   MATURITAS

Long-term use of continuous-combined estrogen-progestin hormone therapy and risk of endometrial cancer

(2011) Amanda I. Phipps et al.   CANCER CAUSES & CONTROL

Menopausal Hormone Therapy and Risk of Endometrial Carcinoma Among Postmenopausal Women in the European Prospective Investigation into Cancer and Nutrition

(2010) N. E. Allen et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Endometrial cancer associated with various forms of postmenopausal hormone therapy: A case control study

(2010) Susanna Jaakkola et al.   INTERNATIONAL JOURNAL OF CANCER

Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement

(2010) Richard J. Santen et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Reproductive factors and postmenopausal hormone use in relation to endometrial cancer risk in the Nurses' Health Study cohort 1976-2004

(2009) Stalo Karageorgi et al.   INTERNATIONAL JOURNAL OF CANCER

Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium

(2009) Sergio Pecorelli   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

Progestational effects of dydrogesterone in vitro, in vivo and on the human endometrium

(2009) Adolf E. Schindler   MATURITAS

Agreement of self-reported estrogen use with prescription data

(2009) Lorenzo Sandini et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Endometrial Cancer in Postmenopausal Women Using Estradiol–Progestin Therapy

(2009) Susanna Jaakkola et al.   OBSTETRICS AND GYNECOLOGY

Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin

(2008) Gerardo Heiss   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Use of Different Postmenopausal Hormone Therapies and Risk of Histology- and Hormone Receptor–Defined Invasive Breast Cancer

(2008) Agnès Fournier et al.   JOURNAL OF CLINICAL ONCOLOGY